Substance Induced Disorders, Schemes and Mind Maps of Psychiatry

Download Substance Induced Disorders and more Schemes and Mind Maps Psychiatry in PDF only on Docsity!

Substance Induced Disorders

Julie Kmiec, DO University of Pittsburgh AOAAM 2018

Objectives

At the end of this lecture, participants should be able to:

❖Understand the difference between substance induced disorders and independent

psychiatric disorders

❖Be able to diagnose substance induced disorder versus independent mood, anxiety,

or psychotic disorder

❖Discuss typical treatment for independent psychiatric disorders

❖Understand the importance of differentiating between substance-induced and

independent psychiatric disorders

DIAGNOSES ASSOCIATED WITH CLASS

OF SUBSTANCE

Substance Anxiety Depress Bipolar Psychotic OC Neuroco gnitive Sleep Delirium Sexual alcohol I/W I/W I/W I/W I/W/P I/W I/W I/W cannabis I I I/W I hallucinogen I I I I I inhalant I I I I/P I opioid W I/W I/W I/W I/W sedative W I/W I/W I/W I/W/P I/W I/W I/W stimulant I/W I/W I/W W I/W I/W I I caffeine I I/W tobacco W Onset during I = intoxication; W = withdrawal P = persisting DSM-5, 2013

DIAGNOSES ASSOCIATED WITH CLASS

OF SUBSTANCE

Substance SUD Intoxication Withdrawal alcohol X X X cannabis X X X hallucinogen X X inhalant X X opioid X X X sedative X X X stimulant X X X caffeine X X tobacco X X DSM-5, 2013

DSM-5 Substance Induced Disorder

❖The disorder represents clinically significant symptomatic presentation of a relevant

mental disorder

❖There is evidence from H&P or labs of both

❖ The disorder developed during or within 1 month of substances intoxication or withdrawal or taking a medication ❖ The involved substance/medication is capable of producing the mental disorder

❖The disorder is not better explained by an independent mental disorder

❖ The disorder preceded the onset of intoxication or withdrawal or exposure to the medication ❖ The full mental disorder persisted for at least 1 month after cessation of acute withdrawal or intoxication or taking the medication

❖The disorder doesn't occur exclusively in course of delirium

❖Disorder causes significant distress or impairment in function

DSM-5,

Symptoms of Substance Induced

Disorders May Be Identical to

Independent Disorders

❖Important to differentiate because they have different prognoses

❖Intoxication and withdrawal induced disorders resolve without psychotropic

medications

❖Occasionally psychotropic medications may be needed for agitation

❖Independent disorders may require psychotropic medications

❖Error in diagnosis may lead to medical mismanagement

SUBSTANCE INDUCED

DEPRESSIVE DISORDERS

Major Depressive Disorder

A. Five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. ❖ Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feels sad, empty, hopeless) or observation made by others (e.g., appears tearful). ( Note: In children and adolescents, can be irritable mood.) ❖ Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day. ❖ Significant weight loss when not dieting or weight gain (e.g., a change of more than 5% of body weight in a month), or decrease or increase in appetite nearly every day. ( Note: In children, consider failure to make expected weight gain.) ❖ Insomnia or hypersomnia nearly every day. ❖ Psychomotor agitation or retardation nearly every day (observable by others). ❖ Fatigue or loss of energy nearly every day. ❖ Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day. ❖ Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective account or as observed by others). ❖ Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide. B. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. C. The episode is not attributable to the physiological effects of a substance or another medical condition. D. Do not include symptoms that are clearly attributable to another medical condition. DSM-5, 2013

Substance Induced Depressive Disorder

A. A prominent and persistent disturbance in mood characterized by depressed mood or

markedly diminished interest or pleasure in all, or almost all, activities.

B. Evidence from the H&P or laboratory findings of both (1) and (2):

1. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal.

2. The involved substance can produce the symptoms in Criterion A.

C. The disturbance is not better explained by a depressive disorder that is not substance

induced. Evidence of an independent depressive disorder may include:

1. The symptoms preceded the onset of the substance use; the symptoms persist for a

substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe

intoxication; or there is evidence of an independent depressive disorder (e.g., a history of recurrent

non-substance related episodes).

D. The disturbance does not occur exclusively during delirium.

E. The disturbance causes clinically significant distress or impairment in social,

occupational, or other important areas of functioning.

DSM-5, 2013

DIAGNOSES ASSOCIATED WITH CLASS

OF SUBSTANCE

Substance Anxiety Depress Bipolar Psychotic OC Neurocog nitive Sleep Delirium Sexual alcohol I/W I/W I/W I/W I/W/P I/W I/W I/W cannabis I I I/W I hallucinogen I I I I I inhalant I I I I/P I opioid W I/W I/W I/W I/W sedative W I/W I/W I/W I/W/P I/W I/W I/W stimulant I/W I/W I/W W I/W I/W I I caffeine I I/W tobacco W Onset during I = intoxication; W = withdrawal P = persisting DSM-5, 2013

Prevalence

❖Lifetime prevalence of substance/medication-induced depressive disorder is 0.26% (Blanco et

al. 2012)

❖ NESARC 12-month prevalence of independent mood disorders were 9.21% in the total sample,

while prevalence of substance-induced mood disorders was less than 1% (Grant et al., 2004)

❖ Langas et al. (2013) looked at patients with SUD and found ❖ 42 had both SUD and MDD ❖ 20 (47.6%) had lifetime history of independent MDD ❖ 10 (23.8%) had history of substance induced depressive disorder (SIDD) only ❖ 12 (28.6%) had history of independent MDD and SIDD

❖ Compared to independent MDD, those with substance-induced depressive disorder only

❖ Had fewer years education ❖ Smoked more cigarettes per day ❖ Had shorter duration of depressive episodes

Diagnosing Substance-Induced

Depression

❖Substance-induced depressions may appear identical to major depressive episodes

(Schuckit & Smith, 1996)

❖However, individuals with substance-induced depressions did not have

❖ an increased family history of major depressive disorder ❖ major depressive episodes are not observed at high rates in their children

❖In patients with SUD, both primary and substance-induced MDD predict future

depression (Nunes et al., 2006)

Course Modifiers

❖ Blanco et al. (2012) found those with substance-induced depressive disorder are more likely:

❖ Male

❖ African-American

❖ Have at most a high school diploma

❖ Lack insurance

❖ Have lower family income

❖ Have higher family history of substance use disorders and antisocial behavior

❖ Have greater 12-month history of stressful life events

❖ Greater number of DSM-IV major depressive disorder criteria

❖ Report feelings of worthlessness, insomnia/hypersomnia, and thoughts of death and suicide

attempts

❖ And less likely to report depressed mood

Comorbidity

❖Comparing individuals with MDD and a comorbid substance use disorder, individuals

with substance induced depressive disorder are more likely to have (Blanco et al., 2012):

❖alcohol use disorder

❖any other substance use disorder

❖histrionic personality disorder

❖And are less likely to have persistent depressive disorder